2020 Speaker List:
Recombinant Protein Therapeutics
[KEYNOTE] Aris N. Economides, PhD, Vice President, Research, Regeneron Pharmaceuticals, Inc.
Katharina Billian-Frey, PhD, Senior Scientist, Protein Engineering, Drug Discovery, Apogenix AG
Ruben J. Boado, PhD, Co-Founder, ArmaGen, Inc.
Alan Epstein, MD, PhD, Professor, Pathology, Keck School of Medicine, University of Southern California (USC)
Jennifer Cochran, PhD, Professor, Bioengineering and Chemical Engineering, and Shriram Chair, Bioengineering, Stanford University
Joachim Feldswich, PhD, Director, Preclinical Development, Affibody AB
Elissa Leonard, PhD, Postdoctoral Research Fellow, Biomedical Engineering, Johns Hopkins University
Bharat Madan, PhD, Postdoctoral Researcher, Pharmaceutical Chemistry, University of Kansas
Shannon K. Oda, PhD, Research Associate, Philip D. Greenberg Laboratory, Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center
Mark Rixon, PhD, Senior Director, Protein Therapeutics, Alpine Immune Sciences
Lu Shan, PhD, Scientist, Antibody Discovery and Protein Engineering, AstraZeneca plc
Stefan Schmidt, PhD, MBA, COO/Head, Operations, BioAtrium AG
Rachita Sumbria, PhD, Associate Professor, Biopharmaceutical Sciences, Keck Graduate Institute
Yariv Wine, PhD, Assistant Professor, Molecular Cell Biology and Biotechnology, Tel Aviv University
Lead and Candidate Selection for Therapeutic Proteins
[KEYNOTE] Peter M. Tessier, PhD, Professor, Pharmaceutical Sciences, Chemical Engineering and Biomedical Engineering, University of Michigan
Karl Griswold, PhD, Associate Professor, Engineering, Dartmouth College
Kate Hastie, PhD, Instructor, La Jolla Institute for Immunology
Vibha Jawa, PhD, Director, Risk Assessment and Clinical Immunogenicity, Merck
Jonathan Kingsbury, PhD, Senior Director, Developability & Preformulation Science, Sanofi
Chang Liu, PhD, Associate Scientist, BioAnalytical Sciences, Genentech
Rajiv Panwar, PhD, Principal Scientist, Magenta Therapeutics
Samantha Phan, Consultant Biologist, Protein BioSciences, Eli Lilly and Company
Ramkrishna (Ramu) Sadhukhan, PhD, Principal Research Scientist, Global Protein Sciences, AbbVie Bioresearch Center
Daniel-Adriano Silva, PhD, Vice President, Head of Research, Neoleukin Therapeutics, Inc.
Max Vásquez, PhD, Head, Computational Biology, Adimab LLC
Sathya Venkataramani, PhD, Associate Director, Biophysics, Janssen Biotherapeutics
Deep Sequencing and Single Cell Analysis for Antibody Discovery
[KEYNOTE] Bryan Briney, PhD, Assistant Professor, Immunology and Microbiology, The Scripps Research Institute
Jarrett Adams, PhD, Associate Director, Toronto Recombinant Antibody Center, Canada
Andrew R.M. Bradbury, MB BS, PhD, CSO, Specifica, Inc.
Sean Carroll, PhD, Associate Director, Molecular Biology, Atreca
Stefan Ewert, PhD, Senior Investigator, Novartis Pharma AG, Switzerland
Elke Glasmacher, PhD, Head, Immunobiology, Roche, Germany
Jimmy Gollihar, PhD, Research Scientist, Army Futures Command, Army Research Laboratory
Ryan Kelly, PhD, Research Scientist, xCella Biosciences
Yana Safonova, PhD, Postdoctoral Fellow, Computer Science and Engineering Department, University of California San Diego
Aude Segaliny, PhD, Group Leader, Assay Biology & Scientific Liaison, Amberstone Biosciences
Vu Truong, PhD, CSO & CEO, R&D, Aridis Pharmaceuticals, Inc.
Navin Varadarajan, PhD, Associate Professor, Chemical and Biomolecular Engineering, University of Houston
Alon Wellner, PhD, Postdoctoral Research, Biomedical Engineering, University of California, Irvine
Alexander Yermanos, Researcher, Biosystems Science and Engineering, ETH Zurich, Switzerland
Engineering Next-Generation Cancer Immunotherapies
[KEYNOTE] Shahram Salek-Ardakani, PhD, Senior Director, Cancer Immunology Discovery, Pfizer
Hamsell Alvarez, PhD, Principal Research Scientist, Immuno-Oncology Discovery, AbbVie
Javier Chaparro-Riggers, PhD, Senior Director, Protein Engineering, Pfizer
Kathryn Henckels, PhD, Senior Scientist, Process Development, Amgen
Michael Hedvat, PhD, Group Leader, Cell Biology, Xencor
Mitchell Ho, PhD, Senior Investigator, National Cancer Institute, NIH
Noor Jailkhani, PhD, Postdoctoral Research Scientist, Koch Institute for Integrative Cancer Research, MIT
Hitoshi Katada, PhD, Research Scientist, Biologics Discovery, Chugai Pharmaceutical Co., Ltd., Japan
Sean H. Lim, MBChB, PhD, Associate Professor, Haematological Oncology, Center for Cancer Immunology, University of Southampton, United Kingdom
Lance L. Munn, PhD, Associate Professor, Department of Radiation Oncology, Massachusetts General Hospital
Govinda Sharma, PhD, Postdoctoral Fellow, Genome Sciences Center, BC Cancer Research Center, Canada
Traian Sulea, PhD, Principal Research Officer, Human Health Therapeutics, National Research Council Canada
Antibody-Drug Conjugates
[KEYNOTE] Rakesh Dixit, PhD, DABT, President & CEO, Bionavigen, LLC
George Octavian Badescu, PhD, Vice President, Scientific Affairs, Heidelberg Pharma AG
Maria J. Costa, PhD, Associate Director, Research, Immune-Onc Therapeutics, Inc.
Tony D’Alessio, PhD, Senior Research Investigator, Oncology Biotherapeutics, Novartis Institutes for Biomedical Research
Susanna Elledge, MSc, Scientist, Chemistry and Chemical Biology, University of California, San Francisco (UCSF)
Mark Glassy, PhD, Chairman, Nascent Biotech, Inc.
Amelie Eriksson Karlström, PhD, Professor, Protein Sciences, Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology
Qing Li, PhD, Scientist, Antibody Discovery & Protein Engineering, AstraZeneca
Adrian Hobson, PhD, Research Fellow, Global Biologics – Antibody Drug Conjugates, AbbVie Bioresearch Center, AbbVie
Bradley Pearse, PhD, Director, Biotherapeutics, Magenta Therapeutics
Siew Schleyer, PhD, Director, Oncology Research, CytomX Therapeutics, Inc.
Edit Tarcsa, PhD, Director and Research Fellow, Drug Metabolism & Pharmacokinetics, Abbvie Bioresearch Center, AbbVie
Jonathan van Dyck, Scientist, Analytical Sciences, Seattle Genetics
Bispecific Antibody Therapeutics
[KEYNOTE] Partha S. Chowdhury, Senior Director, Biologics Research, Sanofi Genzyme
Ulrich Brinkmann, PhD, Expert Scientist and Scientific Director, Roche Pharma Research & Early Development, Roche Innovation Center Munich
Stephen Demarest, PhD, Senior Research Fellow, Lilly Biotechnology Center, Eli Lilly and Company
David J. DiLillo, PhD, Senior Staff Scientist, Immuno-Oncology, Regeneron Pharmaceuticals
Christina Furebring, PhD, Senior Vice President, Preclinical Development, Alligator Bioscience
Steffen Goletz, PhD, Professor and Deputy Head, Biotechnology and Biomedicine, and Vice Director, Institute of Bioengineering, Technical University of Denmark
James Legg, PhD, Senior Vice President, Research, Crescendo Biologics, Ltd.
Shaun Lippow, PhD, Director, Protein Engineering, Atreca, Inc.
Sebastian Meyer, PhD, Chief Operating Officer, Numab Therapeutics AG
Wendy Ritacco, MSc, Senior Scientist III, Global Biologics, AbbVie
Justin Scheer, PhD, Director, Antibody Engineering, Boehringer Ingelheim
Jamie B. Spangler, PhD, Assistant Professor, Biomedical Engineering and Chemical & Biomolecular Engineering, Whiting School of Engineering, Johns Hopkins University
David E. Szymkowski, PhD, Vice President, Cell Biology, Xencor, Inc.
Nathan Trinklein, PhD, Chief Technology Officer, TeneoBio, Inc.
Vector Design and Development for Gene and Cell Therapies
[KEYNOTE] Guangping Gao, PhD, Co-Director, Li Weibo Institute for Rare Diseases Research; Director, Horae Gene Therapy Center and Viral Vector Core; Professor, Microbiology and Physiological Systems, University of Massachusetts Medical School
Annicka Evans, PhD, Scientist I, Analytical Development, Gene Therapy, Biogen
Justin Eyquem, PhD, Principal Investigator, Department of Microbiology and Immunology, University of California San Francisco
Tyler Gibson, PhD, Scientist II, Decibel Therapeutics
Karmella Haynes, PhD, Assistant Professor, Wallace H. Coulter Department of Biomedical Engineering, Emory University
Douglas Jolly, PhD, Executive Vice President, Research & Pharmaceutical Development, Tocagen, Inc.
Jing Liao, PhD, Associate Director, Discovery Biology, LogicBio Therapeutics
Andrew Mercer, PhD, Principal Scientist, Gene Transfer Technologies, REGENXBIO
Francis Szoka, PhD, Professor of Bioengineering, Therapeutic Sciences and Pharmaceutical Chemistry, University of California, San Francisco
Christopher Tipper, PhD, MS, Director of Discovery Research, Ophthalmology, Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary
Jiwu Wang, PhD, President and CEO, Allele Biotech
Ziying Yan, PhD, Research Associate Professor, Department of Anatomy and Cell Biology, The University of Iowa
Peter Yingxiao Wang, PhD, Professor, Bioengineering, Institute of Engineering in Medicine, University of California, San Diego
Gene Therapy Analytics and Manufacturing
[KEYNOTE] Muthiah (Mano) Manoharan, PhD, Senior Vice President, Drug Discovery, Alnylam Pharmaceuticals, Inc.
David Cetlin, Founder & CEO, MockV Solutions LLC
Mark Galbraith, PhD, Head, Quality Control and Analytical Sciences, Spark Therapeutics
Mo Heidaran, PhD, Vice President, Technical, PAREXEL Consulting, PAREXEL International
Arun Alphonse Ignatius, PhD, Principal Scientist, Pharmaceutical Research and Development, Biotherapeutics, Pfizer, Inc.
Jichao (Jay) Kang, PhD, RAC, Director, Analytical Development, Amicus Therapeutics
Alfred Luitjens, Director Cell Technology, Operations, Batavia Biosciences
Lake N. Paul, PhD, President, BioAnalysis, LLC
Jim Richardson, PhD, Senior Science and Standards Liaison, Global Biologics, United States Pharmacopeia
Klaus Richter, PhD, Group Leader, Analytical Ultracentrifugation (AUC) Group, Coriolis Pharma Research
Tanvir Tabish, MSc, Head of Formulation Development, Formulation, Fill and Finish, Takeda
Tristan Thwaites, PhD, Lead Technical Scientist, Industrialization, Cell and Gene Therapy Catapult
Qin Zou, PhD, Associate Research Fellow and Group Leader, Analytical Research and Development, Pfizer, Inc.
Cell Therapy Analytics and Manufacturing
[KEYNOTE]-Mo Heidaran, PhD, Vice President, Technical, PAREXEL Consulting, PAREXEL International
Debaditya Bhattacharya, PhD, Group Leader, Analytical Cell & Gene Therapy, Process & Analytical Development, bluebird bio
Vijay Chiruvolu, PhD, Senior Vice President of Global Process Development - Cell Therapy, Kite Pharma, a Gilead Sciences Company
Dominic Clarke, PhD, ISCT Process & Product Committee Co-Chair and Global Head, Cell Therapy, HemaCare
Ta-Chun Hang, PhD, Senior Scientist, Process Development, bluebird bio
Tony Bou Kheir, PhD, Senior Analytical Development Scientist, Cell and Gene Therapy Catapult
Kelly Kemp, PhD, Director, Process Development, ViaCyte
Sandro Matosevic, PhD, Assistant Professor, Department of Industrial and Physical Pharmacy, Purdue University
Shabnum Patel, PhD, Process Development & Manufacturing Scientist, Center for Cancer Cell Therapy, Stanford University
Jim Richardson, PhD, Senior Science and Standards Liaison, Global Biologics, United States Pharmacopeia
Ilya Shestopalov, PhD, Associate Director, Cell Analytics, bluebird bio
Kuldip Sra, PhD, Senior Director, Crispr Therapeutics
Tristan Thwaites, PhD, Lead Technical Scientist, Industrialization, Cell and Gene Therapy Catapult
Optimizing Biologics Formulation Development
[KEYNOTE] Murali Bilikallahalli, PhD, Vice President and Head of Technical Operations, Acceleron Pharma
Aniket Badkar, PhD, Director, Biologics Product Development, Allergan
Ralf Carrillo, PhD, Associate Principal Scientist, Pharmaceutical Science, Merck
Julie Champion, PhD, Associate Professor, Chemical and Biomolecular Engineering, Georgia Tech
Jessica Ebo, Researcher, Astbury Center for Structural Molecular Biology, University of Leeds, United Kingdom
Flaviu Gruia, PhD, Principal Scientist, Drug Product Analytical Development, Moderna Therapeutics
Kapil Gupta, PhD, Director, Protein Pharmaceutical Development, Biogen
Saeed Izadi, PhD, Scientist, Genentech
Xiaofeng Lu, PhD, Principal Research Scientist, Pharmaceutical Development, AbbVie, Inc.
Krishna M.G. Mallela, PhD, Associate Professor, Pharmaceutical Sciences, University of Colorado
Page McAndrew, PhD, Director, Scientific Communications, West Pharmaceutical Services
Shalini Minocha, PhD, Staff Scientist, Formulation Development, Regeneron
Samantha Pace, PhD, Research Investigator, Bristol-Myers Squibb
Jainik Panchal, PhD, Associate Principal Scientist, Sterile Formulation Sciences, Merck
Lyophilization and Emerging Drying Technologies
[KEYNOTE] Gerhard Winter, PhD, Professor, Chair, Pharmaceutical Technology and Biopharmaceutics, LMU Munchen
Arun Alphonse Ignatius, PhD, Principal Scientist, Pharmaceutical Research and Development, Biotherapeutics, Pfizer, Inc.
Bakul Bhatnagar, PhD, Senior Principal Scientist, Pharmaceutical R&D, BioTherapeutics Pharmaceutical Sciences, Pfizer, Inc.
Pauline Che, MSc, Engineer II, Pharmaceutical Development, Genentech
Benson Gikanga, Senior Engineer, Pharmaceutical Processing and Technology Development, Genentech
[FEATURED PRESENTER] Xiuling Lu, PhD, Associate Professor, Pharmaceutical Sciences, University of Connecticut
Andrew Massetti, Senior Associate Scientist, Protein Pharmaceutical Development, Biogen
Rajiv Nayar, PhD, President, HTD Biosystems, Inc.
Evgenyi Shalaev, PhD, Executive Director, Pharmaceutical Development, Allergan plc
Justin Stanbro, PhD, Associate Principal Scientist, Novel Adjuvants, Formulation & Delivery Technologies, Merck & Co.
Tanvir Tabish, MSc, Head of Formulation Development, Formulation, Fill and Finish, Takeda
Xiaoda Yuan, PhD, Scientist, Pharmaceutical Development, Allergan, Inc.
Protein Aggregation and Emerging Analytical Tools
[KEYNOTE] Peter Schurtenberger, PhD, Professor, Department of Chemistry, Lund University
Paolo Arosio, PhD, Professor, Biochemical Engineering, Department of Chemistry and Applied Biosciences, ETH Zurich
Christoph Brandenbusch, PhD, Group Leader, Biochemical and Chemical Engineering, TU Dortmund
John J. Correia, PhD, Professor, Department of Biochemistry, University of Mississippi Medical Center
Reza Esfandiary, Associate Director, Early Stage Formulation Sciences, BioPharmaceutical Development, AstraZeneca
Jan Jezek, PhD, CSO, Arecor Ltd.
Andrzej Kloczkowski, PhD, Professor, Pediatrics, Nationwide Children’s Hospital and The Ohio State University
Thomas Laue, PhD, Professor Emeritus, Biochemistry and Molecular Biology; Director, Biomolecular Interaction Technologies Center (BITC), University of New Hampshire
Christian Lange, PhD, R&D Biologics Research, Assays and Analytics, Protein Therapeutics, Sanofi-Aventis Deutschland GmbH
Gerhard Winter, PhD, Professor, Chair, Pharmaceutical Technology and Biopharmaceutics, LMU Munchen
Marcel Tigges, PhD, Associate Director, The Janssen Pharmaceutical Companies of Johnson & Johnson
Josh Tokuda, PhD, Postdoctoral Fellow, Biological Relevance and Characterization, Amgen, Inc.
Vishal Toprani, PhD, Development Scientist-I, Pharmaceutical Development, Alexion Pharmaceuticals
Characterization of Biotherapeutics
[KEYNOTE] Elizabeth M. Topp, PhD, Dane O. Kildsig Chair and Department Head, Department of Industrial and Physical Pharmacy, Purdue University
[Featured Presenter] Anup Arumughan, PhD, Principal Scientist, Antibody Analytics, Roche
Gaurav Chauhan, MS, Associate Principal Scientist, Biologics Process Research and Development, Merck & Co., Inc.
Suzanne D’Addio, PhD, Principal Scientist - Discovery Pharmaceutical Sciences, Merck & Co., Inc.
Mark Chiu, PhD, Associate Director, BioTherapeutics Analytical Development, Janssen Research & Development LLC
David Hayes, PhD, Biophysics Consultant, International Solidarity of Scientists
Nate Joh, PhD, Senior Scientist, Biological Relevance and Characterization, Amgen, Inc.
Robert Mayer, PhD, Senior Fellow, Novartis - Global Drug Development, Technical Research & Development, Sandoz GmbH
Mitra Mosharraf, PhD, HTD Biosystems, Inc.
Sheila Mugabe, MSc, Scientist, MacroGenics, Inc.
Sanket Patke, PhD, Senior Scientist, Drug Product Formulation and Process Development, Sanofi
Peter Schurtenberger, PhD, Professor, Department of Chemistry, Lund University
Alayna George Thompson, PhD, Senior Scientist I, Drug Discovery Science & Technology, AbbVie
Riccardo Torosantucci, PhD, Section Head - Formulation & Process Development Frankfurt, Biologics Drug Product Development, Sanofi
Detection and Characterization of Particulates and Impurities
[KEYNOTE] Paolo Arosio, PhD, Professor, Biochemical Engineering, Department of Chemistry and Applied Biosciences, ETH Zurich
Samiul Amin, PhD, Associate Professor, Chemical Engineering, Manhattan College
Richard Cavicchi, PhD, Research Physicist, Biomolecular Measurement Division, Material Measurement Laboratory, National Institute of Standards and Technology
David Cetlin, Founder & CEO, MockV Solutions LLC
Rachel Chen, Scientist II, Analytical Development, Biogen
Danny K. Chou, PharmD, PhD, President, Biopharmaceutical Characterization and Formulation Development, Compassion BioSolution, LLC
Joel F. Cohen-Solal, PhD, Senior Scientist, Global Protein Sciences, AbbVie Bioresearch Center, Inc.
Rui Fang, PhD, Senior Scientist, Sterile Formulation Sciences, Merck & Co., Inc.
Mark Galbraith, PhD, Head, Quality Control and Analytical Sciences, Spark Therapeutics
Tristan Thwaites, PhD, Lead Technical Scientist, Industrialization, Cell and Gene Therapy Catapult
Sandy Wang, MSc, Engineer II, Pharmaceutical Development, Genentech
Boxu Yan, PhD, Senior Director, Analytical Development and Quality Control, Acceleron Pharma
Qin Zou, PhD, Associate Research Fellow and Group Leader, Analytical Research and Development, Pfizer, Inc.
Bioprocess Data Management and Analysis
[KEYNOTE] Cenk Undey, PhD, Executive Director, Process Development, Amgen
Norbert Furtmann, PhD, Head of Data Lab, High Throughput Biologics, Sanofi-Aventis Deutschland GmbH
Jin Sung Hong, PhD, ORISE Research Fellow, Center for Drug Evaluation and Research, FDA
Bryan Jones, PhD, Research Fellow, BioTechnology Discovery Research, Eli Lilly and Company
Meiyappan Lakshmanan, PhD, Research Scientist & Group Leader, Systems Biology, Bioprocessing Technology Institute, A*STAR
Nathan Lewis, PhD, Associate Professor, Department of Pediatrics, University of California, San Diego
Ruojia Li, PhD, Principal Scientist, Statistics Team Lead, Biologics Development, Bristol-Myers Squibb
Yuan Lin, Biologics Solution Lead, Pfizer, Inc.
Jonathan Mott, MS, Scientist, Upstream Process Sciences, Nektar Therapeutics
Anne Richelle, PhD, Senior Specialist - Metabolic Modeling, Global Vaccines, Technical R&D, GlaxoSmithKline Vaccines
Matthew Schinn, PhD, Postdoctoral Researcher, Department of Pediatrics, University of California, San Diego
Khandaker Siddiquee, PhD, Principal Scientist, Abbott Diagnostic Division, Abbott Laboratories
Thomas Zahel, PhD, Head of Innovation, Exputec GmbH
Spin Wang, MS, Co-Founder and CEO, TetraScience
Protein Purification and Recovery
[KEYNOTE] Alois Jungbauer, PhD, Professor and Head, Institute of Bioprocess Science and Engineering, Biotechnology, University of Natural Resources and Life Sciences (BOKU)
Richard Altman, MS, Staff Scientist, Life Science Solutions, Thermo Fisher Scientific
Mark Howarth, PhD, Professor, Biochemistry, University of Oxford
Dennis Karthaus, MSc, Group Leader Cell Culture Sciences, IBA Lifesciences
John K. Kawooya, PhD, Director, Biologics Optimization, Discovery Research, Amgen, Inc.
Wan-Ching Lai, PhD, Principal Scientist, Diagnostics, Abbott Laboratories
Abraham M. Lenhoff, PhD, Allan P. Colburn Professor, Chemical and Biomolecular Engineering, University of Delaware
Simon Messing, PhD, Scientist II, Protein Expression Laboratory, Leidos Biomedical/Frederick National Laboratory for Cancer Research
Timothy M. Pabst, PhD, Principal Scientist, Protein Purification & Downstream Process Development, AstraZeneca
Rumana Rashid, PhD, Lead Scientist, Protein Sciences, Xencor, Inc.
Corey Smith, PhD, Senior Scientist, Abbvie Bioresearch Center
Lu Wang, PhD, Associate Director, CMC Process Development, Teva Pharmaceuticals USA, Inc.
Gregory Weiss, PhD, Professor, Chemistry, Pharmaceutical Sciences, Molecular Biology & Biochemistry, University of California, Irvine
David Wood, PhD, Professor, Chemical and Biomolecular Engineering, Microbiology, Chemistry & Biochemistry, Ohio State University
Yan-ping Yang, PhD, Associate Vice President and Head, Bioprocess R&D, North America, Sanofi Pasteur
Alexei Yeliseev, PhD, Staff Scientist and Leader, Protein Expression Group, NIH
Higher-Throughput Protein Production and Characterization
[KEYNOTE] Renaud Vincentelli, PhD, Head, High-Throughput Protein Production, Structural Biology Core, Architecture et Fonction des Macromolécules Biologiques (AFMB), UMR, CNRS – Aix-Marseille University
Christopher Bahl, PhD, Head, Protein Design, Protein Design Laboratory, Institute for Protein Innovation
Nicola Burgess-Brown, PhD, Principal Investigator, Nuffield Department of Medicine, SGC, University of Oxford
Jörg Birkenfeld, PhD, Section Head, High-Throughput Biologics, R&D Biologics Research/Protein Therapeutics, Sanofi-Aventis Deutschland GmbH
Yongku Cho, PhD, Assistant Professor, Chemical and Biomolecular Engineering, University of Connecticut
Sabine Eichling, PhD, Head, Advanced Formulation Development, NBE Formulation Sciences, AbbVie Deutschland GmbH & Co KG
Markus Haberger, Group Leader, Development Characterization Analytics, Roche Diagnostics GmbH
Liviu Movileanu, PhD, Professor, Physics, Biomedical and Chemical Engineering, Syracuse University
Vel Murugan, PhD, MBA, Research Scientist, Virginia G. Piper Center for Personalized Diagnostics, The Biodesign Institute, Arizona State University
Jürgen Nett, PhD, Director, High-Throughput Expression, Adimab, LLC
Sarah Rue, PhD, Associate Director, Advanced Automation Technologies, Genomics Institute of the Novartis Research Foundation (GNF)
Peng George Wang, PhD, Professor, Pharmacology and Chemical Biology, Baylor College of Medicine
Ernst Weber, PhD, Laboratory Head, Biologics Lead Optimization and Project Leader, Ophthalmology, Bayer Healthcare AG
Renaud Vincentelli, PhD, Head, High-Throughput Protein Production, Structural Biology Core, Architecture et Fonction des Macromolécules Biologiques (AFMB), UMR, CNRS – Aix-Marseille University
Daniel Yoo, Scientist, Therapeutic Discovery, Biologics Optimization, Amgen, Inc.
Engineering Genes, Vectors, Constructs, and Clones
[KEYNOTE] Josh LaBaer, MD, PhD, Executive Director, Biodesign Institute, Arizona State University
Jeffrey Barrick, PhD, Associate Professor, Molecular Biosciences, The University of Texas at Austin
David Burgenson, PhD Candidate, Center for Advanced Sensor Technology (CAST), University of Maryland Baltimore County
Karmella Haynes, PhD, Assistant Professor, Wallace H. Coulter Department of Biomedical Engineering, Emory University
Chava Kimchi-Sarfaty, PhD, Deputy Associate Director for Research, Office of Tissues and Advanced Therapies, CBER, FDA
Antje Krüger, PhD, Postdoctoral Fellow, Michael Jewett Laboratory, Department of Chemical and Biological Engineering, Northwestern University
Meiyappan Lakshmanan, PhD, Research Scientist & Group Leader, Systems Biology, Bioprocessing Technology Institute, A*STAR
Nathan Lewis, PhD, Associate Professor, Department of Pediatrics, University of California, San Diego
Jing Liao, PhD, Associate Director, Discovery Biology, LogicBio Therapeutics
Tomoshi Kameda, PhD, Senior Research Scientist, National Institute of Advanced Industrial Science and Technology
Javin Oza, PhD, Assistant Professor, Chemistry & Biochemistry, California Polytechnic State University, SLO
Harun Rashid, PhD, Senior Principal Scientist, Molecular Technology, Ambrx, Inc.
Samuel Sternberg, PhD, Assistant Professor, Department of Biochemistry and Molecular Biophysics, Columbia University
Recombinant Protein Expression and Production
[KEYNOTE] Phillip Berman, PhD, Distinguished Research Professor, Biomolecular Engineering, University of California, Santa Cruz
Johannes Buyel, Dr. rer. nat., Dr-Ing, Head, Bioprocess Engineering, Fraunhofer Institute for Molecular Biology and Applied Ecology IME
Albor Dobon-Alonso, PhD, Senior Microbiologist, Leaf Expression Systems Ltd.
Charles Glass, PhD, President and CSO, TEGA Therapeutics, Inc.
Olivier Henry, PhD, Associate Professor, Chemical Engineering, Polytechnique Montréal
Nobuko Katagiri, PhD, Research Biologist, Division of Plasma Protein Therapeutics, Office of Tissues and
Takeshi Omasa, PhD, Professor, Department of Material and Life Science, Graduate School of Engineering, Osaka University
Shirley Peters, PhD, Principal Scientist, UCB
Tyson Shepherd, Research Associate, Mark Bathe Laboratory, Department of Biological Engineering, Massachusetts Institute of Technology
Danming Tang, PhD, Technical Development Scientist, Cell Culture, Genentech
Brian Vandahl, PhD, Corporate Vice President, Recombinant Technologies, Global Research Technologies, Novo Nordisk A/S
Bjørn Voldborg, MSc, Director, CHO Cell Line Development, The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark
Richard Wyatt, PhD, Professor, Immunology and Microbiology, Scripps Research Institute
Alexei Yeliseev, PhD, Staff Scientist, Group Leader, LMBB, National Institute on Alcohol Abuse and Alcoholism, National Institute of Health
Optimizing Expression Platforms
[KEYNOTE] John K. Kawooya, PhD, Director, Biologics Optimization, Discovery Research, Amgen, Inc.
Richard Altman, MS, Field Application Scientist, Protein Expression, Biosciences Division, Life Sciences Solutions Group, Thermo Fisher Scientific
Sarah Barker, PhD, Director, Product Development, C-Lab Management Team, Centre for the Commercialization of Antibodies and Biologics (CCAB)
Yves Durocher, PhD, Research Officer, Bioprocess Engineering, National Research Council Canada
Sam Ellis, Vice President, Thomson Instrument Company
Dominic Esposito, PhD, Director, Protein Expression Laboratory, Frederick National Laboratory for Cancer Research
Peter Harms, PhD, Principal Engineer, Cell Culture, Genentech
Ying Huang, MD, PhD, Lab Head, Vaccine Design and Characterization, Preclinical R&D, GSK Vaccines
Dennis Karthaus, Director, Protein Products & Assays, IBA Lifesciences
Edward Kraft, PhD, Senior Scientific Manager, Biomolecular Resources, Genentech
Meiyappan Lakshmanan, PhD, Research Scientist & Group Leader, Systems Biology, Bioprocessing Technology Institute, A*STAR
Balaji Somasundaram, PhD, Strategy and Operations Manager, UQ Protein Expression Facility, The University of Queensland
Bjørn Voldborg, MSc, Director, CHO Cell Line Development, The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark
Jessica Williamson, PhD, Protein Production Lead, UCB Biosciences
Ian Wilkinson, CSO, Absolute Antibody
Xiaotian Zhong, PhD, Senior Principal Scientist, Lab Head, BioMedicine Design, Pfizer Worldwide R&D
Yizhou Zhou, PhD, Scientist II, Cell Line Development, Biogen
Plenary Keynote Panel
[Moderator] Mohammad Tabrizi, PhD, Senior Director, Pharmacology, Ascendis Pharma A/S
Edward Kraft, PhD, Senior Scientific Manager, Biomolecular Resources, Genentech
Ilya Shestopalov, PhD, Associate Director, Cell Analytics, bluebird bio
David E. Szymkowski, PhD, Vice President, Cell Biology, Xencor, Inc.
Alayna George Thompson, PhD, Senior Scientist I, Drug Discovery Science & Technology, AbbVie
Training Seminar Instructors:
David Bramhill, PhD, Founder, Bramhill Biological Consulting, LLC
Andrew R.M. Bradbury, MB BS, PhD, CSO, Specifica, Inc.
Matthew Brown, PhD, Applications Manager, Bioscience, Malvern Panalytical, Inc.
Trevor Deeks, PhD, QA/QC and GMP Consultant, Deeks Pharmaceutical Consulting Services, LLC
Thomas Laue, PhD, Professor Emeritus, Biochemistry and Molecular Biology; Director, Biomolecular Interaction Technologies Center (BITC), University of New Hampshire
James D. Marks, MD, PhD, Chief of Performance Excellence, Zuckerberg San Francisco General Hospital and Trauma Center; Professor of Anesthesia, UCSF Department of Anesthesia and Perioperative Care
Kevin Mattison, PhD, Principal Scientist, Malvern Pananalytical, Inc.
Kevin Zen, PhD, Executive Director, Analytical Characterization, Formulation Development and Biologics Manufacturing, AnaptysBio Inc.
Short Course Instructors:
Wasfi AlAzzam, PhD, CSO, TechnoPharmaSphere (TPS)
Richard Altman, Field Application Scientist, Protein Expression, Biosciences Division, Life Sciences Solutions Group, Thermo Fisher Scientific
Henry C. Chiou, PhD, Director, Cell Biology, Life Science Solutions, Thermo Fisher Scientific
Rakesh Dixit, PhD, DABT, President & CEO, Bionavigen, LLC
Dominic Esposito, PhD, Director, Protein Expression Laboratory, Frederick National Laboratory for Cancer Research
Deb Harris, Managing Director, Industry Special Services, BDO USA LLP
Thomas Laue, PhD, Professor Emeritus, Biochemistry and Molecular Biology; Director, Biomolecular Interaction Technologies Center (BITC), University of New Hampshire
Kevin Mattison, PhD, Principal Scientist, Malvern Pananalytical, Inc.
George Octavian Badescu, PhD, Vice President, Scientific Affairs, Heidelberg Pharma AG
Traian Sulea, PhD, Principal Research Officer, Human Health Therapeutics, Biotechnology Research Institute, National Research Council Canada